Open Menu Close Menu

To honor a visionary scientist who has conceptually advanced BRCA1/2 related research that has led to improvements in clinical care. The prize will be considered for a broad range of basic, translational and clinical BRCA1/2 cancer researchers worldwide. Outstanding candidates will be those whose research has produced seminal advances in the field and who continue to drive BRCA1/2 related research towards the ultimate goal of mitigating the adverse impact of deleterious BRCA1/2 and related mutations.